Skip to content

Krzysztof Brzozka

  • PhD, MBA
  • CSO, EVP
  • Selvita SA
  • 11h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 2717CitationsNumber of citations received by Krzysztof's publications. Updated daily.

Recent publications

  • A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia

    • Czardybon W
    • Windak R
    • Gołas A
    • et al.
    N/AReaders
    3Citations
    Get full text
  • MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma

    • Zhan Y
    • Guo J
    • Yang W
    • et al.
    N/AReaders
    15Citations
    Get full text

Professional experience

CSO, EVP

Selvita SA

January 2007 - Present

Co-authors (188)

  • George Best
  • Karl-Klaus Conzelmann
  • Tomasz Rzymski

Other IDs